Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer

被引:195
作者
Georgievska, B [1 ]
Kirik, D [1 ]
Björklund, A [1 ]
机构
[1] Lund Univ, Wallenberg Neurosci Ctr, Dept Physiol Sci, S-22184 Lund, Sweden
关键词
behavior; Parkinson's disease; sprouting; stereology;
D O I
10.1006/exnr.2002.8006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of sustained (up to 9 months) striatal overexpression of glial cell line derived neurotrophic factor (GDNF) on lesioned nigrostriatal dopamine (DA) neurons was studied using a recombinant lentiviral (rLV) vector to deliver GDNF into the striatum 4 weeks prior to the creation of an intrastriatal 6-hydroxydopamine lesion. The results of the amphetamine-induced rotation suggested an initial partial protection followed by a complete recovery, whereas the spontaneous motor behaviors remained impaired. There was a clear protection of the nigral tyrosine hydroxylase (TH)-positive neurons in the rLV-GDNF group compared to rats injected with the control vector encoding green fluorescent protein (GFP) (70 and 20% of the intact side, respectively). However, the striatal TH+ fiber density was equally reduced (to 20% of the intact side) in both groups. Further morphological analyses indicated that the nigrostriatal projections of the DA neurons were indeed preserved in the GDNF group. The axonal projections were visualized using two independent methods: First, retrograde labeling of the nigral cell bodies by intrastriatal Fluoro-Gold injections showed that the majority of rescued cells in the GDNF group had preserved axonal projections to striatum. Second, injections of a recombinant adeno-associated viral vector expressing GFP into the nigra was used to anterogradely fill the DA neurons and their projections with GFP protein. GFP immunostaining clearly demonstrated that the fibers of the nigral DA cells were preserved along the nigrostriatal pathway and innervated large parts of the striatum, but did not express TH at detectable levels. In addition, fiber sprouting was observed in the globus pallidus, entopeduncular nucleus, and substantia nigra, corresponding to areas where GDNF protein was released. The lack of functional recovery in the spontaneous motor behaviors may, at least in part, be explained by this extensive aberrant fiber sprouting in the downstream striatal target nuclei and/or decreased synthesis of dopamine in the striatum. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:461 / 474
页数:14
相关论文
共 42 条
[1]   Lentiviral vectors as a gene delivery system in the mouse midbrain:: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF [J].
Bensadoun, JC ;
Déglon, N ;
Tseng, JL ;
Ridet, JL ;
Zurn, AD ;
Aebischer, P .
EXPERIMENTAL NEUROLOGY, 2000, 164 (01) :15-24
[2]   Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease [J].
BilangBleuel, A ;
Revah, F ;
Colin, P ;
Locquet, I ;
Robert, JJ ;
Mallet, J ;
Horellou, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8818-8823
[3]   Parkinson disease gene therapy moves toward the clinic [J].
Björklund, A ;
Lindvall, O .
NATURE MEDICINE, 2000, 6 (11) :1207-1208
[4]   Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease [J].
Bjorklund, A ;
Rosenblad, C ;
Winkler, C ;
Kirik, D .
NEUROBIOLOGY OF DISEASE, 1997, 4 (3-4) :186-200
[5]   Towards a neuroprotective gene therapy for Parkinson's disease:: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model [J].
Björklund, A ;
Kirik, D ;
Rosenblad, C ;
Georgievska, B ;
Lundberg, C ;
Mandel, RJ .
BRAIN RESEARCH, 2000, 886 (1-2) :82-98
[6]   GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR SUPPORTS SURVIVAL OF INJURED MIDBRAIN DOPAMINERGIC-NEURONS [J].
BOWENKAMP, KE ;
HOFFMAN, AF ;
GERHARDT, GA ;
HENRY, MA ;
BIDDLE, PT ;
HOFFER, BJ ;
GRANHOLM, ACE .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 355 (04) :479-489
[7]   Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor [J].
Choi-Lundberg, DL ;
Lin, Q ;
Schallert, T ;
Crippens, D ;
Davidson, BL ;
Chang, YN ;
Chiang, YWL ;
Qian, JA ;
Bardwaj, L ;
Bohn, MC .
EXPERIMENTAL NEUROLOGY, 1998, 154 (02) :261-275
[8]   Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat [J].
Connor, B ;
Kozlowski, DA ;
Schallert, T ;
Tillerson, JL ;
Davidson, BL ;
Bohn, MC .
GENE THERAPY, 1999, 6 (12) :1936-1951
[9]   Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap [J].
Conway, JE ;
Zolotukhin, S ;
Muzyczka, N ;
Hayward, GS ;
Byrne, BJ .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8780-8789
[10]   Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease [J].
Déglon, N ;
Tseng, JL ;
Bensadoun, JC ;
Zurn, AD ;
Arsenijevic, Y ;
De Almeida, LP ;
Zufferey, R ;
Trono, D ;
Aebischer, P .
HUMAN GENE THERAPY, 2000, 11 (01) :179-190